e-Article
The proportion of CD34+ CD38low or neg myeloblasts, but not side population frequency, predicts initial response to induction therapy in patients with newly diagnosed acute myeloid leukemia.
Document Type
Article
Author
Source
Subject
*MYELOID leukemia
*THERAPEUTICS
*
Language
ISSN
0887-6924
Abstract
A letter to the editor in response to the article "The proportion of CD34+CD38low or neg myeloblasts, but not side population frequency, predicts initial response to induction therapy in patients with newly diagnosed acute myeloid leukemia" published in a previous 2013 issue is presented.